Literature DB >> 23288847

Trypanosoma brucei S-adenosylmethionine decarboxylase N terminus is essential for allosteric activation by the regulatory subunit prozyme.

Nahir Velez1, Chad A Brautigam, Margaret A Phillips.   

Abstract

Human African trypanosomiasis is caused by a single-celled protozoan parasite, Trypanosoma brucei. Polyamine biosynthesis is a clinically validated target for the treatment of human African trypanosomiasis. Metabolic differences between the parasite and the human polyamine pathway are thought to contribute to species selectivity of pathway inhibitors. S-adenosylmethionine decarboxylase (AdoMetDC) catalyzes a key step in the production of the polyamine spermidine. We previously showed that trypanosomatid AdoMetDC differs from other eukaryotic enzymes in that it is regulated by heterodimer formation with a catalytically dead paralog, designated prozyme, which binds with high affinity to the enzyme and increases its activity by up to 10(3)-fold. Herein, we examine the role of specific residues involved in AdoMetDC activation by prozyme through deletion and site-directed mutagenesis. Results indicate that 12 key amino acids at the N terminus of AdoMetDC are essential for prozyme-mediated activation with Leu-8, Leu-10, Met-11, and Met-13 identified as the key residues. These N-terminal residues are fully conserved in the trypanosomatids but are absent from other eukaryotic homologs lacking the prozyme mechanism, suggesting co-evolution of these residues with the prozyme mechanism. Heterodimer formation between AdoMetDC and prozyme was not impaired by mutation of Leu-8 and Leu-10 to Ala, suggesting that these residues are involved in a conformational change that is essential for activation. Our findings provide the first insight into the mechanisms that influence catalytic regulation of AdoMetDC and may have potential implications for the development of new inhibitors against this enzyme.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23288847      PMCID: PMC3576127          DOI: 10.1074/jbc.M112.442475

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights.

Authors:  M Cherry; D H Williams
Journal:  Curr Med Chem       Date:  2004-03       Impact factor: 4.530

2.  Putrescine activation of Trypanosoma cruzi S-adenosylmethionine decarboxylase.

Authors:  Tracy Clyne; Lisa N Kinch; Margaret A Phillips
Journal:  Biochemistry       Date:  2002-11-05       Impact factor: 3.162

3.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

4.  Mechanism of human S-adenosylmethionine decarboxylase proenzyme processing as revealed by the structure of the S68A mutant.

Authors:  William D Tolbert; Yang Zhang; Sarah E Cottet; Eric M Bennett; Jennifer L Ekstrom; Anthony E Pegg; Steven E Ealick
Journal:  Biochemistry       Date:  2003-03-04       Impact factor: 3.162

5.  Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.

Authors:  Robert H Barker; Hanlan Liu; Bradford Hirth; Cassandra A Celatka; Richard Fitzpatrick; Yibin Xiang; Erin K Willert; Margaret A Phillips; Marcel Kaiser; Cyrus J Bacchi; Aixa Rodriguez; Nigel Yarlett; Jeffrey D Klinger; Edmund Sybertz
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

Review 6.  Polyamine-dependent gene expression.

Authors:  A C Childs; D J Mehta; E W Gerner
Journal:  Cell Mol Life Sci       Date:  2003-07       Impact factor: 9.261

7.  Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).

Authors:  Bhushan Nagar; William G Bornmann; Patricia Pellicena; Thomas Schindler; Darren R Veach; W Todd Miller; Bayard Clarkson; John Kuriyan
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

8.  Polyamine metabolism: a potential therapeutic target in trypanosomes.

Authors:  C J Bacchi; H C Nathan; S H Hutner; P P McCann; A Sjoerdsma
Journal:  Science       Date:  1980-10-17       Impact factor: 47.728

9.  Structure of bovine trypsinogen at 1.9 A resolution.

Authors:  A A Kossiakoff; J L Chambers; L M Kay; R M Stroud
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

10.  Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate.

Authors:  John Regan; Steffen Breitfelder; Pier Cirillo; Thomas Gilmore; Anne G Graham; Eugene Hickey; Bernhard Klaus; Jeffrey Madwed; Monica Moriak; Neil Moss; Chris Pargellis; Sue Pav; Alfred Proto; Alan Swinamer; Liang Tong; Carol Torcellini
Journal:  J Med Chem       Date:  2002-07-04       Impact factor: 7.446

View more
  9 in total

1.  Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity.

Authors:  Anthony J Brockway; Oleg A Volkov; Casey C Cosner; Karen S MacMillan; Stephen A Wring; Thomas E Richardson; Michael Peel; Margaret A Phillips; Jef K De Brabander
Journal:  Bioorg Med Chem       Date:  2017-08-03       Impact factor: 3.641

2.  Genetic validation of Trypanosoma brucei glutathione synthetase as an essential enzyme.

Authors:  Chelsea Pratt; Suong Nguyen; Margaret A Phillips
Journal:  Eukaryot Cell       Date:  2014-03-07

3.  The Major Protein Arginine Methyltransferase in Trypanosoma brucei Functions as an Enzyme-Prozyme Complex.

Authors:  Lucie Kafková; Erik W Debler; John C Fisk; Kanishk Jain; Steven G Clarke; Laurie K Read
Journal:  J Biol Chem       Date:  2016-12-20       Impact factor: 5.157

4.  Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.

Authors:  Oleg A Volkov; Casey C Cosner; Anthony J Brockway; Martin Kramer; Michael Booker; Shihua Zhong; Ariel Ketcherside; Shuguang Wei; Jamie Longgood; Melissa McCoy; Thomas E Richardson; Stephen A Wring; Michael Peel; Jeffrey D Klinger; Bruce A Posner; Jef K De Brabander; Margaret A Phillips
Journal:  ACS Infect Dis       Date:  2017-04-07       Impact factor: 5.084

5.  Product feedback regulation implicated in translational control of the Trypanosoma brucei S-adenosylmethionine decarboxylase regulatory subunit prozyme.

Authors:  Yanjing Xiao; Suong Nguyen; Sok Ho Kim; Oleg A Volkov; Benjamin P Tu; Margaret A Phillips
Journal:  Mol Microbiol       Date:  2013-05-02       Impact factor: 3.501

6.  Relief of autoinhibition by conformational switch explains enzyme activation by a catalytically dead paralog.

Authors:  Oleg A Volkov; Lisa Kinch; Carson Ariagno; Xiaoyi Deng; Shihua Zhong; Nick Grishin; Diana R Tomchick; Zhe Chen; Margaret A Phillips
Journal:  Elife       Date:  2016-12-15       Impact factor: 8.140

7.  Pyrimidine Salvage Enzymes Are Essential for De Novo Biosynthesis of Deoxypyrimidine Nucleotides in Trypanosoma brucei.

Authors:  Christopher Leija; Filipa Rijo-Ferreira; Lisa N Kinch; Nick V Grishin; Nicole Nischan; Jennifer J Kohler; Zeping Hu; Margaret A Phillips
Journal:  PLoS Pathog       Date:  2016-11-07       Impact factor: 6.823

Review 8.  Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter.

Authors:  Ian H Gilbert
Journal:  Parasitology       Date:  2013-08-09       Impact factor: 3.234

9.  A dual regulatory circuit consisting of S-adenosylmethionine decarboxylase protein and its reaction product controls expression of the paralogous activator prozyme in Trypanosoma brucei.

Authors:  Manish M Patel; Oleg A Volkov; Christopher Leija; Andrew Lemoff; Margaret A Phillips
Journal:  PLoS Pathog       Date:  2018-10-26       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.